KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardant Health (GH) EPS (Weighted Average and Diluted) (2019 - 2026)

Guardant Health's EPS (Weighted Average and Diluted) history spans 7 years, with the latest figure at -$1.0 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 11.11% to -$1.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.31, a 7.02% increase, with the full-year FY2025 number at -$3.32, up 6.74% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$1.0 in Q4 2025 for Guardant Health, down from -$0.74 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for GH hit a ceiling of -$0.67 in Q2 2023 and a floor of -$2.25 in Q2 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$1.08 across 5 years, with a median of -$0.95 in 2021.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 134.38% in 2022 and later skyrocketed 70.22% in 2023.
  • Tracing GH's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.89 in 2021, then tumbled by 53.93% to -$1.37 in 2022, then fell by 18.25% to -$1.62 in 2023, then surged by 44.44% to -$0.9 in 2024, then dropped by 11.11% to -$1.0 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for GH at -$1.0 in Q4 2025, -$0.74 in Q3 2025, and -$0.8 in Q2 2025.